Nichino America Announces Executive Appointments and Promotions
WILMINGTON, DE - What could possibly be more exciting than the appointment of one new leader? How about three. Recently announcing the shakeup of its executive ring, Nichino America Inc. (NAI), known for its crop protection products, revealed that it has tapped Jeffrey Johnson to serve as its President and CEO; Dustin Simmons as its Commercial Vice President; and Dr. Lydia Cox as Vice President, Regulatory and Scientific Affairs. The promotions and appointments will officially go into effect July 1, 2021.
Johnson holds the role of President, and will soon be named Chief Executive Officer of NAI in addition to his current position. According to a press release, he has also been promoted to Managing Executive Officer of Nihon Nohyaku Company, a parent company of NAI, and will lead the Global Strategy Project Team for the Nichino Group Companies.
Starting with the Nichino Group in 1997, Johnson began as the Commercial Development Manager of Nihon Nohyaku America. He was then named Vice President of the newly formed NAI in 2001 and was appointed President in 2002.
Dustin Simmons will join Johnson in being promoted, assuming the newly created role of Commercial Vice President. In his position, Simmons will oversee marketing; strategic planning; business development; U.S., Mexico, and Canada third party licensing; and subsidiary business in Mexico (Nichino Mexico). He will continue to report to Johnson in his new role.
Simmons joined NAI in 2008 and has held several positions within the company including Sales Representative, Marketing Manager, Director of Marketing, and Director of Business Development and Strategic Planning.
Throughout Simmons' time with the company, he has made many contributions to the development and growth of NAI.
Rounding out the list of new leaders is Dr. Lydia Cox who has been promoted to Vice President of Regulatory and Scientific Affairs for NAI. In her new position, Cox will oversee all regulatory, scientific, and governmental affairs activities for the company as well as safety, product quality, and formulations. She is responsible for North America for all active ingredients and brands at the federal and state levels. Cox too will report to Johnson in her new role.
Cox joined NAI in 2013 as Director of Regulatory Affairs, and has managed her team for the past 8 years. Notably, she has overseen efforts for full federal registrations for tolfenpyrad and pyrifluquinazon, as well as the expanded label registration for orthosulfamuron in the tree and vine markets.
Congratulations to all three leaders as they take on these new roles!